FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Qian Changgeng 2. Date of Event Requiring Statement (Month/Day/Year) 06/06/2007 3. Issuer Name and Ticker or Trading Symbol CURIS INC [CRIS] (Last) (First) (Middle) 45 MOULTON STREET 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP, Research & Preclinical Dev 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) CAMBRIDGE, MA 02138 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock (8) 5,014 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Qualified stock option (right to buy)	  (1)	07/02/2011	Common stock	20,000	$ 4.72	D	Â
Qualified stock option (right to buy)	  (1)	06/05/2012	Common stock	10,125	$ 1.5	D	Â
Qualified stock option (right to buy)	  (1)	09/25/2012	Common stock	9,375	$ 1.09	D	Â
Qualified stock option (right to buy)	  (1)	05/13/2013	Common stock	35,000	$ 2.43	D	Â
Qualified stock option (right to buy)	  (6)	06/25/2014	Common stock	24,000	$ 4.56	D	Â
Qualified stock option (right to buy)	  (7)	06/01/2015	Common stock	24,000	$ 3.98	D	Â
Qualified stock option (right to buy)	  (5)	01/10/2016	Common stock	15,136	$ 4.03	D	Â
Qualified stock option (right to buy)	05/31/2008(2)	05/31/2016	Common stock	20,000	$ 1.57	D	Â
Qualified stock option (right to buy)	  (4)	09/13/2016	Common stock	53,253	$ 1.57	D	Â
Non-qualified stock option (right to buy)	  (5)	01/10/2016	Common stock	864	$ 4.03	D	Â
Non-qualified stock option (right to buy)	  (1)	05/31/2016	Common stock	20,000	$ 1.57	D	Â
Non-qualified stock option (right to buy)	  (4)	09/13/2016	Common stock	46,747	$ 1.57	D	Â
Qualified stock option (right to buy)	  (3)	06/05/2012	Common stock	10,000	$ 1.5	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Qian Changgeng 45 MOULTON STREET CAMBRIDGE, MA 02138	Â	Â	  VP, Research & Preclinical Dev	Â

Signatures

/s/ Michael P. Gray, attorney-in-fact		06/08/2007
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Options are fully vested and exercisable.
(2)	All options will vest two years from the grant date, or May 31, 2008.
(3)	All options will vest on November 6, 2007.
(4)	Options will vest over a period of four years with 25% of the stock options vesting the first anniversary of the grant date, or September 13, 2007, and an additional 6.25% of the shares during each successive three-month period thereafter until the option is fully vested on the fourth anniversary of the grant date, or September 13, 2010, subject to continued employment, with non-qualified options vesting first. All stock options will expire 10 years from date of grant and the grant date for each option is 10 years prior to the expiration date. None of these options were vested as of June 6, 2007.
(5)	Options vest over a period of four years with 25% of the stock options vesting the first anniversary of the grant date, or January 10, 2007, and an additional 6.25% of the shares during each successive three-month period thereafter until the option is fully vested on the fourth anniversary of the grant date, or January 10, 2010, subject to continued employment. All stock options will expire 10 years from date of grant and the grant date for each option is 10 years prior to the expiration date. 10,754 of the qualified options and 247 of the non-qualified options remain unvested as of June 6, 2007.
(6)	Options vest over a period of four years with 25% of the stock options vesting the first anniversary of the grant date, or June 25, 2005, and an additional 6.25% of the shares during each successive three-month period thereafter until the option is fully vested on the fourth anniversary of the grant date, or June 25, 2008, subject to continued employment. All stock options will expire 10 years from date of grant and the grant date for each option is 10 years prior to the expiration date. 7,500 options remain unvested at June 6, 2007.
(7)	Options vest over a period of four years with 25% of the stock options vesting the first anniversary of the grant date, or June 1, 2006, and an additional 6.25% of the shares during each successive three-month period thereafter until the option is fully vested on the fourth anniversary of the grant date, or June 1, 2009, subject to continued employment. All stock options will expire 10 years from date of grant and the grant date for each option is 10 years prior to the expiration date. 12,000 options remain unvested at June 6, 2007.
(8)	Shares owned were purchased under the 2000 Employee Stock Purchase Plan.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.